Not Signed In -
Ibuprofen Oral Drops |
Infants' Advil; Infants' Motrin; PediaCare Fever |
Clinical Trial: Effects of Pretreatment With Ibuprofen in Post- ECT Headache
This study is not yet open for patient recruitment.
Verified by Norwegian University of Science and Technology November 2005
|
Purpose
| Condition | Intervention |
|---|---|
| Mental Disorders | Drug: Ibuprofen |
MedlinePlus related topics: Mental Health
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Secondary Outcomes: ECT paramenters
Expected Total Enrollment: 30
Study start: March 2006; Expected completion: December 2007
Last follow-up: June 2007; Data entry closure: December 2007
The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment.
Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally, blinded to patient, physician and treatment team.
Patients will be asked about their headache with a visual analogue scale (VAS) 2 hours prior to and within 2 hours after treatment, 2-month, 6- month and 1 year follow-up [5].
Eligibility
Inclusion Criteria:
- Patients receiving ECT
Exclusion Criteria:
- Pregnancy, contraindications to ibuprofen
Location and Contact Information
Norway
Østmarka Psychiatric Department, St. OLavs Hospital, University Hospital of Trondheim, Trondheim, Norway
Olav Morten Linaker, MD PhD, Principal Investigator
Olav Morten Linaker, MD PhD, Principal Investigator, Norwegian University of Science and Technology
More Information
Last Updated: December 8, 2005
Record first received: November 24, 2005
ClinicalTrials.gov Identifier: NCT00258791
Health Authority: Norway: Norwegian Social Science Data Services
ClinicalTrials.gov processed this record on 2006-01-10
email this page
print this page
bookmark this page
feedback on this page
